Cardiac fibroblast cellular anisotropy is determined by YAP-dependent cellular contractility and ECM production
Daniel Pereira-SousaiD, Pau GuillamatiD, Francesco NiroiD, Vladimír VinarskýiD, Soraia FernandesiD, Marco CassaniiD, Stefania PagliariiD, Xavier TrepatiD, Marco RasponiiD, Jorge Oliver‐De La CruziD, Giancarlo ForteiD
Abstract
Cardiac fibroblasts (CFbs) determine the topological arrangement and the anisotropy of the heart tissue - essential features for maintaining tissue integrity and function - through the production and remodeling of the extracellular matrix (ECM). Under pathological conditions, CFbs can activate into myofibroblasts and promote maladaptive ECM remodeling that may lead to heart failure. Yes-Associated Protein (YAP) - a key player in cardiac fibrosis onset - has been implicated in CFb activation but its role in coordinating the supracellular organization of CFbs and in shaping the instructive properties of the ECM remains poorly understood. We addressed these questions by generating CFbs from wild-type (WT) and YAP knockout (KO) human embryonic stem cells. YAP depletion reduced the expression of cardiogenic markers and altered the transcriptomic profile of ECM- and contractility-related genes. We further demonstrated that YAP expression is required for CFbs monolayer alignment, and its absence resulted in reduced ECM deposition, decreased anisotropy, and diminished force generation. Pharmacological inhibition of cell contractility closely mirrored YAP KO phenotype, suggesting that YAP regulates both monolayer organization and ECM structure through its control over contractility. ECM cross-seeding experiments confirmed the role of ECM as a structural guide for cellular alignment. Moreover, cardiomyocytes cultured on KO CFb-derived ECM exhibited impaired sarcomere organization and altered calcium dynamics. Together, these findings demonstrate that YAP activity in CFbs governs the structural and functional properties of the ECM, influencing both fibroblast alignment and cardiomyocyte activity. Moreover, they underscore the critical role of YAP in maintaining the supracellular organization and mechanical integrity of cardiac tissue.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- FWCI
- 4.32
- Field percentile
- top 12%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Myofibroblast Ccn3 is regulated by Yap and Wwtr1 and contributes to adverse cardiac outcomes
M. Flinn, S. Alvarez-Argote, … C. C. O'Meara·bioRxiv·Dec 1, 2022
- Human pluripotent stem cell-derived cardiomyocytes align under cyclic strain when guided by cardiac fibroblasts
D. Mostert, B. Groenen, … C. Bouten·bioRxiv·Feb 16, 2021
- YAP1 Contributes to The Development of Contractile Force and Sarcomere Maturation in Human Pluripotent Stem Cell Derived Cardiomyocytes
Vladimír Vinarský, Stefania Pagliari, … Giancarlo Forte·Cell Death DiscoveryPeer-reviewed·Nov 10, 2025
- Cardiac fibroblasts regulate cardiomyocyte hypertrophy through dynamic regulation of type I collagen
Q. Meng, S. L. K. Bowers, … J. D. Molkentin·bioRxiv·May 25, 2022
- YAP dysregulation triggers hypertrophy by CCN2 secretion and TGFβ uptake in human pluripotent stem cell-derived cardiomyocytes
Orlando Chirikian, Mohamed A. Faynus, … Beth L. Pruitt·bioRxiv·Jun 3, 2024
- Exogenous extracellular matrix proteins decrease cardiac fibroblast activation in stiffening microenvironment through CAPG